Key | % Net Assets |
---|---|
GlaxoSmithKline | 5.6% |
Unilever | 5.1% |
British American Tobacco | 5.0% |
Imperial Tobacco | 4.6% |
Other | 79.7% |
Name | % Net Assets |
---|---|
GlaxoSmithKline | 5.6% |
Unilever | 5.1% |
British American Tobacco | 5.0% |
Imperial Tobacco | 4.6% |
Royal Dutch Shell 'B' | 4.5% |
Diageo | 3.3% |
Restaurant Group | 3.2% |
Pearson | 3.1% |
William Hill | 3.1% |
Dechra Pharmaceuticals | 3.0% |
No asset data available.
Date | 27-Mar-2024 |
---|---|
NAV | 2,013.60p |
Currency | GBP |
Change | -2.90p |
% | -0.14% |
YTD change | -2.90p |
YTD % | -0.14% |
Fund Inception | 01/02/1971 |
---|---|
Fund Manager | n/a |
TER | - |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research